Four prominent U.S. health organizations have jointly issued a set of guidelines that reconceptualize cardiovascular care for women and girls. Published Monday in the journal Circulation, the “Female Life Stage” framework was developed by the American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists and the Society for Maternal‑Fetal Medicine. It proposes a holistic, lifespan‑focused approach that ties hormonal and emotional factors to heart health, aiming to help clinicians detect and prevent disease earlier.
New Framework Highlights Lifelong Risk
The societies note that cardiovascular disease (CVD) remains the leading cause of death among women worldwide, accounting for more than 400,000 U.S. deaths each year, according to the American Heart Association and the Centers for Disease Control. The American Heart Association projects that six in ten U.S. women will experience at least one form of CVD by 2050. The new report adds that nearly one‑third of women aged 20 to 44 are expected to develop CVD by that date, up from less than one‑in‑four currently.
Dr. Mariell Jessup, chief science and medical officer of the American Heart Association, emphasized the urgency, saying, “Women make up more than half the population, and their heart health must be a part of everyday care across medicine.”
Life‑Stage Specific Guidance
The framework divides a woman’s life into four distinct stages, each marked by biological shifts unique to females. The first stage begins with menarche, typically occurring between ages 8 and 15. The second stage spans the establishment of regular ovulatory cycles and the years when pregnancy most often occurs, roughly from the late teens through age 44. The third stage covers perimenopause, generally ages 45 to 51, and the fourth stage includes post‑menopause, ages 51 and older.
Pregnancy is described as a natural “stress test” that can reveal hidden cardiovascular risk because of intense hormonal, emotional and physical changes. Dr. Molly Siegel, an obstetrician‑gynecologist and maternal‑fetal medicine specialist at Massachusetts General Hospital, explained that many high‑risk pregnancy complications are linked to underlying heart disease. She urged that obstetric findings be communicated to primary‑care physicians and cardiologists for ongoing monitoring.
Pediatricians are encouraged to watch for early warning signs during puberty, such as irregular periods, heavy menstrual flow, menarche before age 10, or mental‑health conditions like eating disorders. For women approaching menopause, clinicians should assess symptoms such as sleep disturbances or mood changes, which may also signal cardiovascular risk. Post‑menopausal women over 50 face the highest risk of heart attack, stroke or heart failure, partly because estrogen levels decline; the framework stresses that proactive attention in earlier stages can mitigate these outcomes.
Implications for Clinicians
Siegel highlighted the shift from isolated specialty visits to coordinated, longitudinal care. “Traditionally, people think of OB/GYN and cardiology as separate fields, but now we’re talking about assessing risk over a lifetime, and that really requires multidisciplinary, longitudinal care and thought,” she said. She added that the framework’s release is recent, so systemic changes may take time, but she hopes it will spark collaboration across disciplines.
By framing each biological transition as a window for prevention, detection and management, the guidelines aim to embed heart‑health considerations into routine care for women of all ages. The societies anticipate that widespread adoption will improve cardiovascular outcomes and reduce the projected rise in disease prevalence.
Mitchell Landsberg is a Senior Technology Correspondent at News Raise. He covers consumer electronics, artificial intelligence, software developments, and digital privacy trends.
